Inventor · disambiguated record
Shudong Wang
Also filed as: WANG SHUDONG
25 granted patents·23 pending applications·280 citations·filing 1999–2024
96Inventor score
Files withCYCLACEL LTD18AUCENTRA THERAPEUTICS PTY LTD11WANG SHUDONG5UNIV SOUTH AUSTRALIA3AUCENTRA HOLDINGS PTY LTD1
Top patents by PatentIndex Score
48 records- 0192US6531479B2Anti-cancer compoundsCYCLACEL LTD·Filed 2001·Granted Mar 11, 2003·52 cites·23 claims
- 0291US6699854B2Anti-cancer compoundsCYCLACEL LTD·Filed 2002·Granted Mar 2, 2004·40 cites·26 claims
- 0388US7897605B2Pyrimidine compoundsCYCLACEL LTD·Filed 2008·Granted Mar 1, 2011·14 cites·6 claims
- 0483US10479785B2N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsUNIV SOUTH AUSTRALIA·Filed 2016·Granted Nov 19, 2019·3 cites·29 claims
- 0582US8309550B2Kinase inhibitors and their use as pharmaceutical agentsLUO YING·Filed 2011·Granted Nov 13, 2012·9 cites·9 claims
- 0682US6472507B1Carrier based drug delivery systemCYCLACEL LTD·Filed 1999·Granted Oct 29, 2002·57 cites·40 claims
- 0781US7427627B2N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compoundsCYCLACEL LTD·Filed 2006·Granted Sep 23, 2008·6 cites·25 claims
- 0880US7576091B2Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinasesCYCLACEL LTD·Filed 2006·Granted Aug 18, 2009·7 cites·17 claims
- 0980US7262202B2Inhibitors of cyclin dependent kinases as anti-cancer agentCYCLACEL LTD·Filed 2003·Granted Aug 28, 2007·13 cites·41 claims
- 1079US6992169B2Carrier based drug delivery systemCYCLACEL LTD·Filed 2002·Granted Jan 31, 2006·9 cites·40 claims
- 1178US7902361B2Pyrimidin-4-yl-3, 4-thione compounds and their use in therapyCYCLACEL LTD·Filed 2006·Granted Mar 8, 2011·7 cites·28 claims
- 1278US7432260B2Pyrimidine compoundsCYCLACEL LIMTED·Filed 2004·Granted Oct 7, 2008·17 cites·34 claims
- 1378US7388015B2N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compoundsCYCLACEL LTD·Filed 2004·Granted Jun 17, 2008·13 cites·25 claims
- 1477US2025059178A1N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsAucentra Thereapeutics Pty LTD·Filed 2024·Application pending·0 cites
- 1572US9492811B2Zeolite and redox oxide combined catalyst bodyOGUNWUMI STEVEN BOLAJI·Filed 2010·Granted Nov 15, 2016·2 cites·15 claims
- 1670US11970491B2N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Granted Apr 30, 2024·0 cites·17 claims
- 1768US7153931B1Transport vectorsCYCLACEL LTD·Filed 1999·Granted Dec 26, 2006·15 cites·93 claims
- 1866US2020283431A1N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsUNIV SOUTH AUSTRALIA·Filed 2019·Application pending·0 cites
- 1961US10188985B2Zeolite and redox oxide combined catalyst bodyCORNING INC·Filed 2016·Granted Jan 29, 2019·0 cites·12 claims
- 2061US2025049796A1Use of 4-thiazol-n-(pyridin-2-yl)pyrimidin-2-amine derivatives in combination therapies for cancerAUCENTRA THERAPEUTICS PTY LTD·Filed 2023·Application pending·0 cites
- 2161US2025049795A1Use of 5-(2-((5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)amino)-5-fluoropyrimidin-4-yl)-n,4-dimethylthiazol-2-amine in combination therapies for cancerAUCENTRA THERAPEUTICS PTY LTD·Filed 2023·Application pending·0 cites
- 2260US11325900B25-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agentsAUCENTRA HOLDINGS PTY LTD·Filed 2019·Granted May 10, 2022·1 cites·25 claims
- 2356US2023310427A1New therapeutic use of rilpivirineUNIV SOUTH AUSTRALIA·Filed 2021·Application pending·0 cites
- 2456US2023092876A15-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agentsAUCENTRA THERAPEUTICS PTY LTD·Filed 2022·Application pending·0 cites
- 2555USRE49850EN-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compoundsAUCENTRA THERAPEUTICS PTY LTD·Filed 2016·Granted Feb 27, 2024·0 cites·41 claims
- 2655US7337731B2Conjoined folding tableCHANGZHOU QIAOYU GROUP CO LTD·Filed 2004·Granted Mar 4, 2008·15 cites·9 claims
- 2753US2023339889A1Derivatives of 2-oxo-n-(4-(pyrimidin-4-yloxy/thio)phenyl)-1,2-dihydropyridine-3-carboxamide for use as protein kinase inhibitors for therapyAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Application pending·0 cites
- 2852US2007185134A1Inhibitors of cyclin dependent kinases as anti-cancer agentCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 2952US2023181580A1Treatment of proliferative diseases of the cnsAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Application pending·0 cites
- 3051US2023399325A1Succinate and crystal form thereof as therapeuticsAUCENTRA THERAPEUTICS PTY LTD·Filed 2021·Application pending·0 cites
- 3151US2011092490A1Pyrimidines, triazines and their use as pharmaceutical agentsUNIV NOTTINGHAM·Filed 2009·Application pending·0 cites
- 3250US12398132B2Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as therapeutic agentsAUCENTRA THERAPEUTICS PTY LTD·Filed 2020·Granted Aug 26, 2025·0 cites·15 claims
- 3349US2010298131A1Catalyst For Hydrogen Production By Autothermal Reforming, Method Of Making Same And Use ThereofNI CHANGJUN·Filed 2008·Application pending·0 cites
- 3446US11566024B2Tartrate of selective CDK9 inhibitor and crystal form thereofCHANGZHOU QIANHONG BIOPHARMA CO LTD·Filed 2019·Granted Jan 31, 2023·0 cites·14 claims
- 3544US2005215548A1Bisarylsulfonamide compounds and their use in cancer therapyCYCLACEL LTD·Filed 2004·Application pending·0 cites
- 3643US2009215805A14-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase InhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 3743US2024158391A1Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridin-3-yl) pyrimidin-2- amine for treating proliferative diseases and conditionsAUCENTRA THERAPEUTICS PTY LTD·Filed 2020·Application pending·0 cites
- 3840US2009318446A14-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in TherapyCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 3939US2006241297A1Pyridinylamino-pyrimidine derivatives as protein kinase inhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 4038US2008318954A1CompoundsCYCLACEL LTD·Filed 2005·Application pending·0 cites
- 4137US2007021419A12-Aminophenyl-4-phenylpyrimidines as kinase inhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 4236US9062039B2Therapeutic compoundsCHANGZHOU LE SUN PHARMACEUTICALS LTD·Filed 2013·Granted Jun 23, 2015·0 cites·10 claims
- 4333US11111245B2Derivatives of N-cycloalkyl/heterocycloalkyl-4-(imidazo[1,2-a]pyridine)pyrimidin-2-amine as therapeutic agentsAUCENTRA THERAPEUTICS PTY LTD·Filed 2018·Granted Sep 7, 2021·0 cites·18 claims
- 4433US2005288307A1Anti-viral compoundsWANG SHUDONG·Filed 2005·Application pending·0 cites
- 4533US2005282843A1Therapeutic applications of 2-substituted 4-heteroarylpyrimidinesWANG SHUDONG·Filed 2005·Application pending·0 cites
- 4630US2009137572A12-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disordersWANG SHUDONG·Filed 2005·Application pending·0 cites
- 4724US2012003132A1Process for catalytic deoxygenation of coal mine methaneWANG SHUDONG·Filed 2010·Application pending·0 cites
- 4820US8829003B2Compounds for treating proliferative disordersWANG SHUDONG·Filed 2011·Granted Sep 9, 2014·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Shudong Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →